Public Profile

ACE Biotech

ACE Biotech, officially known as ACE Biotech Co., Ltd., is a leading player in the biotechnology industry, headquartered in China. Founded in 2010, the company has established a strong presence in major operational regions across Asia and beyond, focusing on innovative solutions in biopharmaceuticals and diagnostics. Specialising in the development of cutting-edge bioproducts, ACE Biotech offers a range of unique services, including custom antibody production and advanced molecular diagnostics. Their commitment to quality and innovation has positioned them as a trusted partner in the biotech sector, with notable achievements in research collaborations and product development. With a reputation for excellence, ACE Biotech continues to drive advancements in biotechnology, contributing significantly to healthcare solutions and scientific research globally.

DitchCarbon Score

How does ACE Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

ACE Biotech's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

ACE Biotech's reported carbon emissions

ACE Biotech, headquartered in CN, currently does not have available carbon emissions data for recent years, nor specific reduction targets or climate pledges outlined in their initiatives. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate a need for enhanced transparency and accountability in their environmental practices. As the industry increasingly prioritises sustainability, ACE Biotech's future climate commitments will be crucial in aligning with global efforts to reduce greenhouse gas emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ACE Biotech's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. ACE Biotech is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ACE Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Hygeia Health

CN
Health Services
Updated about 17 hours ago

Pro1Med Inc

US
Health Services
Updated 11 days ago

Trinity Consultants

US
Health Services
Updated 11 days ago

Caris Life Sciences

US
Health Services
Updated 11 days ago

Krystal Fruits

US
Health Services
Updated 11 days ago

AcroMetrix LLC

US
Health Services
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers